All Drug
Common Medicines
Oncology
Hematology
Hepatology
Chronic Diseases
Department of Endocrinology
Orphan drugs
Tumor area
Drug selection
Medical Information
-
Precautions for taking clopidogrel: risk of pancreatitis, liver function monitoring, and drug interactions
During the use of clopidogrel, it i...
2026-07-28 17:29:12 -
Tabooned population of Trelagliptin: information for patients with type 1 diabetes, diabetes ketoacidosis and severe liver and kidney dysfunction
Trelagliptin is only applicable to ...
2026-07-28 17:27:31 -
Management of side effects of clopidogrel: How to deal with nasopharyngitis, headache, and rash
The drug can delay the degradation ...
2026-07-28 17:25:32 -
Trelagliptin Usage Guide
Trelagliptin only needs to be taken...
2026-07-28 17:23:18 -
Precautions for taking Relugole: QT/QTc interval prolongation, hepatotoxicity, and drug interactions
Rulugoli reduces the secretion of l...
2026-07-27 17:16:17 -
Taboo population of Relugolix and risk of drug combination use
Rulugoli reduces the secretion of l...
2026-07-27 17:13:20 -
Management of side effects of Rui Lugoli: hot flashes, fatigue, and elevated blood sugar
Rulugoli reduces the secretion of l...
2026-07-27 17:11:22 -
Relugolix Medication Guidelines
Rulugoli reduces the secretion of l...
2026-07-27 17:09:36